Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W E Robinson

Showing results (31-40 of 79) with videos related to

Pageof 8
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1988
Role of protein N-glycosylation in pathogenesis of human immunodeficiency virus type 1D C Montefiori, W E Robinson, W M Mitchell
AIDS Research and Human Retroviruses|April 1, 1989
In vitro evaluation of mismatched double-stranded RNA (ampligen) for combination therapy in the treatment of acquired immunodeficiency syndromeD C Montefiori, W E Robinson, W M Mitchell
Antiviral Research|July 13, 2001
Mismatched double-stranded RNA (polyI-polyC(12)U) is synergistic with multiple anti-HIV drugs and is active against drug-sensitive and drug-resistant HIV-1 in vitroR J Essey, B R McDougall, W E Robinson
Virology|April 1, 1990
Complement-mediated antibody-dependent enhancement of HIV-1 infection requires CD4 and complement receptorsW E Robinson, D C Montefiori, W M Mitchell
Antiviral Research|January 1, 1988
Mismatched dsRNA (ampligen) induces protection against genomic variants of the human immunodeficiency virus type 1 (HIV-1) in a multiplicity of target cellsD C Montefiori, W E Robinson, W M Mitchell
Lancet (London, England)|April 9, 1988
Will antibody-dependent enhancement of HIV-1 infection be a problem with AIDS vaccines?W E Robinson, D C Montefiori, W M Mitchell
Antiviral Research|April 1, 1989
Antibody-independent, complement-mediated enhancement of HIV-1 infection by mannosidase I and II inhibitorsD C Montefiori, W E Robinson, W M Mitchell
AIDS Research and Human Retroviruses|January 1, 1987
Evidence that mannosyl residues are involved in human immunodeficiency virus type 1 (HIV-1) pathogenesisW E Robinson, D C Montefiori, W M Mitchell
Biochemical and Biophysical Research Communications|December 16, 1987
A human immunodeficiency virus type 1 (HIV-1) infection-enhancing factor in seropositive seraW E Robinson, D C Montefiori, W M Mitchell
Lancet (London, England)|April 9, 1988
Antibody-dependent enhancement of human immunodeficiency virus type 1 infectionW E Robinson, D C Montefiori, W M Mitchell
Pageof 8

Showing results (31-40 of 79) with videos related to

Sort By:
Pageof 8
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1988
Role of protein N-glycosylation in pathogenesis of human immunodeficiency virus type 1D C Montefiori, W E Robinson, W M Mitchell
AIDS Research and Human Retroviruses|April 1, 1989
In vitro evaluation of mismatched double-stranded RNA (ampligen) for combination therapy in the treatment of acquired immunodeficiency syndromeD C Montefiori, W E Robinson, W M Mitchell
Antiviral Research|July 13, 2001
Mismatched double-stranded RNA (polyI-polyC(12)U) is synergistic with multiple anti-HIV drugs and is active against drug-sensitive and drug-resistant HIV-1 in vitroR J Essey, B R McDougall, W E Robinson
Virology|April 1, 1990
Complement-mediated antibody-dependent enhancement of HIV-1 infection requires CD4 and complement receptorsW E Robinson, D C Montefiori, W M Mitchell
Antiviral Research|January 1, 1988
Mismatched dsRNA (ampligen) induces protection against genomic variants of the human immunodeficiency virus type 1 (HIV-1) in a multiplicity of target cellsD C Montefiori, W E Robinson, W M Mitchell
Lancet (London, England)|April 9, 1988
Will antibody-dependent enhancement of HIV-1 infection be a problem with AIDS vaccines?W E Robinson, D C Montefiori, W M Mitchell
Antiviral Research|April 1, 1989
Antibody-independent, complement-mediated enhancement of HIV-1 infection by mannosidase I and II inhibitorsD C Montefiori, W E Robinson, W M Mitchell
AIDS Research and Human Retroviruses|January 1, 1987
Evidence that mannosyl residues are involved in human immunodeficiency virus type 1 (HIV-1) pathogenesisW E Robinson, D C Montefiori, W M Mitchell
Biochemical and Biophysical Research Communications|December 16, 1987
A human immunodeficiency virus type 1 (HIV-1) infection-enhancing factor in seropositive seraW E Robinson, D C Montefiori, W M Mitchell
Lancet (London, England)|April 9, 1988
Antibody-dependent enhancement of human immunodeficiency virus type 1 infectionW E Robinson, D C Montefiori, W M Mitchell
Pageof 8